search
for
 About Bioline  All Journals  Testimonials  Membership  News


Indian Journal of Medical Sciences
Medknow Publications on behalf of Indian Journal of Medical Sciences Trust
ISSN: 0019-5359 EISSN: 1998-3654
Vol. 61, Num. 7, 2007, pp. 419-421

Indian Journal of Medical Sciences, Vol. 61, No. 7, July, 2007, pp. 419-421

Letter To Editor

Cryptosporidiosis in a relapsed case of Hodgkin's disease

Department of Medical Oncology, Tata Memorial Hospital, Parel, Mumbai
Correspondence Address:Medical Oncology Dept., Tata Memorial Hospital, Parel, Mumbai - 400 012 drkaranth1@rediffmail.com

Code Number: ms07070

Sir,

Cryptosporidiosis is the leading cause of diarrhea due to protozoal infections worldwide. It constitutes 24% of patients of acquired immunodeficiency syndrome (AIDS) with diarrhea compared to only 6% of immunocompetent persons. [1]

Association of Cryptosporidiosis with cancerous illnesses is not as robust as with AIDS. Here we report a case of Cryptosporidiosis in a relapsed Hodgkin′s disease (HD).

This boy presented to our institution with subacute onset rapidly progressive paraparesis of 3 weeks. He was diagnosed with HD 8 years ago, for which he had received adequate therapy. He developed large-volume watery diarrhea with mild abdominal cramps on admission; 8-10 bowel movements/ 24 h, during night time.

Stool contained mucus and few inflammatory cells but not blood. On day 12, oocysts of Cryptosporidium were identified in the stool by modified acid fast bacilli (AFB) stain [Figure - 1]. He received oral Azithromycin for 5 days as the most effective drug Paromomycin could not be procured.

The frequency of stools reduced; and after a week, reexamination of stool was negative for Cryptosporidium. In a study done by Shreedharan et al., the incidence of cryptosporidiosis was 1.3% in 560 cancer patients evaluated, and none were positive for human immunodeficiency virus antibodies. [2] We suggest routine screening of stool for Cryptosporidium in all patients with malignant neoplasm with persistent diarrhea in view of low cell-mediated immunity.

Cryptosporidiosis was thought to be a rare infection of little or no importance until 1982, when the AIDS epidemic began. The parasite is transmitted through waterborne sources. It has an incubation period of up to 2 weeks. Risk factors for a healthy person include international travel, contact with cattle, contact with persons >2 to 11 years of age with diarrhea, and freshwater swimming.

Most (90%) patients have profuse watery diarrhea containing mucus but rarely blood or leucocytes, which usually lasts for 2 weeks. Other features include abdominal cramps in 80%, fever in 20-30%, weight loss in 75%, vomiting in more than 40%.

The diagnosis can be made by detecting oocysts using modified acid fast staining on microscopical examination of stool. There is no antimicrobial chemotherapeutic agent that will reliably eradicate the organism.

In patients with AIDS, the best treatment is improvement of immune function with highly active antiretroviral therapy, which also helps resolve Cryptosporidium infection. If highly active antiretroviral therapy is not possible or effective, combination therapy with an antimicrobial agent and an antidiarrheal agent will continue to be the standard treatment for cryptosporidial diarrhea. Paromomycin (250-500 mg q.i.d., 4 weeks), azithromycin and (most recently) nitazoxanide are commonly used.

The absence of effective therapy highlights the need to ensure that infection is avoided. [3] Cryptosporidiosis can be effectively controlled by boiling water, filtering through one-micron filter, ozonization; and minimizing contact with sources of infection, young animals and water in lakes.

References

1.Guerrant RL. Cryptosporidiosis: An emerging, highly infectious threat. Emerg Infect Dis 1997;3:51-7.  Back to cited text no. 1  [PUBMED]  
2.Sreedharan A, Jayshree RS, Sridhar H. Cryptosporidiosis among cancer patients: An observation. J Diarrhoeal Dis Res 1996;14:211-3.  Back to cited text no. 2  [PUBMED]  
3.Abubakar I, Aliyu Sh, Arumugam C, Hunter P, Usman N. Prevention and treatment of Cryptosporidiosis in immunocompromized patients. Cochrane Database Syst Rev 2007;1:CD004932.  Back to cited text no. 3    

Copyright 2007 - Indian Journal of Medical Sciences


The following images related to this document are available:

Photo images

[ms07070f1.jpg]
Home Faq Resources Email Bioline
© Bioline International, 1989 - 2024, Site last up-dated on 01-Sep-2022.
Site created and maintained by the Reference Center on Environmental Information, CRIA, Brazil
System hosted by the Google Cloud Platform, GCP, Brazil